Frankfurt, Germany

Tilo Hniopek

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Curasan Ag. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tilo Hniopek: Innovator in Biodegradable Composite Materials

Introduction

Tilo Hniopek is a notable inventor based in Frankfurt am Main, Germany. He has made significant contributions to the field of regenerative medicine through his innovative work on biodegradable composite materials. His inventions aim to address critical needs in medical applications, particularly in bone reconstruction.

Latest Patents

Tilo Hniopek holds a patent for a biodegradable composite material. This invention relates to a biologically degradable composite material and a process for its preparation. The composite material is designed to serve as a bone reconstruction material, which can be utilized in regenerative medicine. It is especially effective as a temporary filler for bone defects, facilitating bone regeneration.

Career Highlights

Hniopek is associated with Curasan AG, a company that focuses on innovative solutions in the field of regenerative medicine. His work at Curasan AG has allowed him to contribute to advancements in medical technology, particularly in the development of materials that promote healing and recovery.

Collaborations

Tilo Hniopek has collaborated with notable colleagues, including Fabian Peters and Wolf-Dietrich Huebner. These collaborations have further enhanced the research and development efforts within his field.

Conclusion

Tilo Hniopek's contributions to biodegradable composite materials represent a significant advancement in regenerative medicine. His innovative approach to creating effective solutions for bone reconstruction showcases the potential of his work in improving medical outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…